HOOKIPA Pharma Inc (HOOK)
3.81
+0.06
(+1.60%)
USD |
NASDAQ |
Nov 05, 16:00
3.81
0.00 (0.00%)
After-Hours: 18:14
HOOKIPA Pharma Enterprise Value: -40.04M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -40.04M |
| November 01, 2024 | -39.15M |
| October 31, 2024 | -39.65M |
| October 30, 2024 | -38.96M |
| October 29, 2024 | -40.24M |
| October 28, 2024 | -39.35M |
| October 25, 2024 | -39.75M |
| October 24, 2024 | -38.46M |
| October 23, 2024 | -39.05M |
| October 22, 2024 | -37.77M |
| October 21, 2024 | -37.67M |
| October 18, 2024 | -36.38M |
| October 17, 2024 | -35.89M |
| October 16, 2024 | -38.56M |
| October 15, 2024 | -41.03M |
| October 14, 2024 | -40.54M |
| October 11, 2024 | -40.44M |
| October 10, 2024 | -38.66M |
| October 09, 2024 | -39.35M |
| October 08, 2024 | -38.26M |
| October 07, 2024 | -37.37M |
| October 04, 2024 | -37.08M |
| October 03, 2024 | -36.58M |
| October 02, 2024 | -36.98M |
| October 01, 2024 | -36.98M |
| Date | Value |
|---|---|
| September 30, 2024 | -34.60M |
| September 27, 2024 | -35.20M |
| September 26, 2024 | -35.69M |
| September 25, 2024 | -35.10M |
| September 24, 2024 | -32.62M |
| September 23, 2024 | -32.03M |
| September 20, 2024 | -30.25M |
| September 19, 2024 | -30.45M |
| September 18, 2024 | -31.44M |
| September 17, 2024 | -29.85M |
| September 16, 2024 | -29.06M |
| September 13, 2024 | -27.77M |
| September 12, 2024 | -26.69M |
| September 11, 2024 | -24.90M |
| September 10, 2024 | -28.57M |
| September 09, 2024 | -29.26M |
| September 06, 2024 | -30.25M |
| September 05, 2024 | -26.59M |
| September 04, 2024 | -26.78M |
| September 03, 2024 | -26.69M |
| August 30, 2024 | -25.40M |
| August 29, 2024 | -25.60M |
| August 28, 2024 | -25.99M |
| August 27, 2024 | -21.24M |
| August 26, 2024 | -23.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-85.79M
Minimum
Sep 25 2023
458.51M
Maximum
May 18 2021
49.32M
Average
-13.24M
Median
Jun 10 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
| Oragenics Inc | 1.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.10M |
| Revenue (Quarterly) | 1.29M |
| Total Expenses (Quarterly) | 21.19M |
| EPS Diluted (Quarterly) | -1.52 |
| Profit Margin (Quarterly) | -1.48K% |
| Earnings Yield | -113.4% |
| Normalized Earnings Yield | -110.63 |